Background Obesity is known to be associated with an increased risk of gastric cardia cancer but not with noncardia cancer. In terms of gastric dysplasia, few studies have evaluated its relationship with obesity. In addition, no study on the relationship between obesity and the risk of gastric cancer has analyzed the status of Helicobacter pylori infection. Methods A case-control study was designed to investigate the relationship between obesity and the risk of gastric cancer and dysplasia adjusted for the status of H. pylori infection in Koreans. Nine hundred ninety-eight gastric cancer patients, 313 gastric dysplasia patients, and 1,288 subjects with normal endoscopic findings were included. Results As gender differences could be the largest confounding factor, the risk of gastric cancer and dysplasia with an increasing body mass index (BMI) was analyzed in men and women, separately, and was adjusted for age, smoking, drinking, family history of gastric cancer, H. pylori infection, atrophic gastritis, intestinal metaplasia, and serum pepsinogen I/pepsinogen II ratio. Obesity (BMI 25 kg/m 2 or greater but less than 30 kg/m 2 ) was associated with increased risk of early gastric cancer [adjusted odds ratio (aOR) 1.657; 95 % confidence interval (CI) 1.086-2.528; P = 0.019] and well or moderately differentiated adenocarcinoma (aOR 1.566; 95 % CI 1.011-2.424; P = 0.044) compared with normal BMI status (BMI \ 23 kg/m 2 ) in men. Obesity was related to gastric dysplasia (aOR 2.086; 95 % CI 1.011-4.302; P = 0.047) in women. Conclusions The effect of obesity on gastric cancer showed a gender difference. That is, in men it was related to increased risk of early gastric cancer and well or moderately differentiated adenocarcinoma, but it was associated with gastric dysplasia in women regardless of H. pylori infection in Korea. Further research into this difference is necessary.
Introduction
Despite the decreasing incidence of gastric cancer in recent decades worldwide, it remains the fourth commonest cancer in the world and the third-leading cause of cancer-related death in men and the fifth-leading cause of cancer-related death in women [1] . Gastric cancer is classified as gastric noncardia cancer and cardia cancer depending on the anatomical location of the lesion, and these two types of gastric cancer have distinct epidemiologic and clinical characteristics. The incidence of gastric noncardia cancer has gradually declined as a result of changing lifestyles, whereas that of cardia cancer has increased sharply in Western countries [2, 3] . There is evidence of an increased risk of gastric noncardia cancer related to chronic Helicobacter pylori infection [4] , tobacco smoking [5] , alcohol abuse [6] , salty and smoked food [7] , and low consumption of fresh fruits and vegetables [8] . By contrast, gastric cardia cancer may be related to gastroesophageal reflux [9] , white race [10] , male gender [10] , and tobacco smoking [11] . H. pylori infection has been verified to be a key factor in gastric noncardia cancer, whereas the role of H. pylori infection in gastric cardia cancer remains controversial [12] .
Obesity has increased steadily worldwide. There is sufficient evidence of a positive relationship between obesity and the risk of colon cancer, postmenopausal breast cancer, endometrial cancer, renal cell cancer, and adenocarcinoma of the esophagus [13] . On the other hand, previous studies have shown mixed results with regard to the relationship between obesity and gastric cancer. Recently, several meta-analyses have found that overweight and obese individuals are more likely to be at risk of gastric cardia cancer but not of noncardia cancer [14, 15] . However, no study has explored the effect of H. pylori infection on the relationship between obesity and the risk of gastric cancer, which may be an important confounder. In addition, stages of gastric cancer, including early and advanced stages, have yet to be clearly identified.
Gastric dysplasia is considered a premalignant lesion of intestinal-type gastric cancer, and H. pylori is known to cause gastric cancer progressively from atrophic gastritis to intestinal metaplasia, dysplasia, and finally cancer [4] . Unlike in the case of colorectal adenomas, for which obesity is associated with an increased risk [16] , few studies have explored the relationship between obesity and the risk of gastric dysplasia [17] .
Given the above background, the present study aimed to determine whether obesity, as measured by the body mass index (BMI), is related to gastric cancer and dysplasia after adjustment for H. pylori infection and other confounding factors in men and women. In addition, the study examines whether obesity is related to various subgroups of gastric cancer stratified by the location, stage, and histologic subtype of the tumor.
Materials and methods

Study subjects
This study was designed as a single-center case-control study. Patients histologically diagnosed with gastric cancer or dysplasia were prospectively enrolled at Seoul National University Bundang Hospital between June 2003 and August 2013. All participants were ethnically Korean, and most had undergone standard endoscopy as part of a screening program for premalignant gastric mucosal lesions or gastric cancer. All patients with gastric cancer or dysplasia were histologically confirmed by the surgical or endoscopic submucosal dissection specimen. However, for subjects who could not undergo surgery or endoscopic submucosal dissection because of metastasis or patient comorbidity, a diagnosis of gastric cancer was made with endoscopic biopsy. Patients who had another underlying type of cancer and a history of gastric resection were excluded from this study. In this study, gastric cancer is defined as gastric carcinomas including well, moderately, and poorly differentiated tubular adenocarcinomas, papillary adenocarcinomas, mucinous adenocarcinomas, signet ring cell carcinomas, and undifferentiated carcinomas. Those subjects who underwent endoscopy for screening or complained of mild dyspepsia and agreed to receive four types of H. pylori studies in advance in the same study period but did not show any evidence of gastric cancer or dysplasia, mucosa-associated lymphoid tissue lymphoma, or esophageal cancer were assigned to control groups All patients and controls received endoscopy from N.K. Each participant completed an informed consent form and a questionnaire about his or her family history of having first-degree relatives with gastric cancer, smoking and alcohol consumption habits, and history of H. pylori eradication under the supervision of a well-trained interviewer before endoscopy. This study was approved by the Institutional Review Board of Seoul National University Bundang Hospital on January 29, 2014 (Institutional Review Board number B-1401/234-110).
Determination of the H. pylori infection status For the determination of the H. pylori infection status, ten biopsy specimens were taken from the gastric mucosa of each patient (two biopsy specimens from each of the greater curvature of the antrum and body and three specimens from each of the lesser curvature of the antrum and body) during upper endoscopy. Among these ten specimens, four were used for the histologic evaluation of H. pylori infection by modified Giemsa staining [18] . Another four specimens from the four gastric mucosa areas mentioned earlier were used for H. pylori culturing. The remaining two specimens from the lesser curvature of the antrum and body were analyzed with a rapid urease test (CLOtest; Delta West, Bentley, Australia). All biopsy specimens were examined by an experienced pathologist (H.S.L) who was unaware of patient details. Immunoglobulin G specific for H. pylori was screened by an enzyme-linked immunosorbent assay in each subject's serum (Genedia H. pylori enzyme-linked immunosorbent assay; Green Cross Medical Science, Eumsung, South Korea), and the Korean strain was used as an antigen in this H. pylori antibody test [19] . If the result of at least one of these four tests (histologic evaluation, rapid urease test, culturing, H. pylori serologic test) was positive or the patient had a history of H. pylori eradication, the patient was determined as positive for H. pylori infection. The patients with all negative results from these four tests and no history of H. pylori eradication were diagnosed as negative for H. pylori infection.
Evaluation of gastric atrophy and intestinal metaplasia
To evaluate gastric atrophy by the serum pepsinogen test, a fasting serum sample was collected from patients, and serum concentrations of pepsinogen I and pepsinogen II were measured using the latex-enhanced turbidimetic immunoassay (Shima Laboratories, Tokyo, Japan). A pepsinogen I/pepsinogen II ratio less than 3.0 is generally accepted as indicating atrophy [20] .
To evaluate further the severity of gastric atrophy and intestinal metaplasia, updated Sydney system scores were applied to the four biopsy specimens after the hematoxylin and eosin stain.
Clinicopathologic characteristics
Baseline characteristics of subjects, including their age, gender, smoking status, drinking status, first-degree familial history of gastric cancer, and BMI, were assessed. Their height and weight were checked or measured at the time of endoscopy in the endoscopy room, and the BMI was computed as weight in kilograms per square surface area in square meters (kg/m 2 [21] . Surgical specimens of patients with gastric cancer were evaluated according to gross and histologic features and the tumor location by a pathologist (H.S.L) based on the seventh edition of the American Journal Committee on Cancer staging manual. Early gastric carcinomas (EGCs) were defined as invasive carcinomas confined to the mucosa and/ or submucosa with or without lymph node metastases regardless of tumor size. Advanced gastric carcinomas (AGCs) were defined as carcinomas invading the muscularis propria or beyond. In the case of patients with no surgery, multiple modalities including endoscopy, endoscopic ultrasonography, and computed tomography were synthesized to determine the tumor location. Gastric cardia cancer was defined as cancer located within 2 cm below the gastroesophageal junction. Tumors arising in the distal part of this area were defined as gastric noncardia cancer. Histologic type was classified into differentiated type (well-differentiated or moderately differentiated adenocarcinoma) or undifferentiated type (poorly differentiated adenocarcinoma or signet ring cell carcinoma) according to Japanese guideline [22] .
Statistical analysis
Categorical variables were analyzed by a chi square test, and continuous variables were analyzed by Student's t test. The effects of BMI on the risk of gastric cancer and dysplasia were represented as odds ratios (ORs) with the 95 % confidence interval (CI) by logistic regression in men and women. In multivariate analyses, all risk estimates were adjusted for the following potential confounding factors: age (in years), smoking status, drinking status, family history of gastric cancer, atrophic gastritis by histologic evaluation, intestinal metaplasia by histologic evaluation, and the pepsinogen I/pepsinogen II ratio. Statistical significance was set to 0.05, and all statistical analyses were conducted using PASW Statistics version 20.0 (IBM, Armonk, NY, USA).
Results
Characteristics of subjects
In this study, 998 patients with gastric cancer (663 males and 335 females) and 313 patients with gastric dysplasia (214 males and 99 females) were enrolled during the study period, and 1,288 subjects (628 males and 660 females) were included as control subjects. The gender-specific baseline characteristics of the patients with gastric cancer and dysplasia and the controls are presented in Tables 1  and 2 . The males and females with gastric cancer and dysplasia were older, had higher incidence of H. pylori infection, more histologic atrophy and intestinal metaplasia, and lower mean serum pepsinogen I/pepsinogen II ratio than the controls. There were more current/exsmokers in the patients with gastric cancer than in the controls for the males. The females with gastric cancer were more likely than the controls to have a first-degree family history of gastric cancer, be a current/ex-smoker, and a drinker. In males, there was a statistically significant difference between the mean BMI of patients with gastric cancer and that of the controls (23.27 ± 2.98 kg/m 2 for gastric cancer patients vs 23.63 ± 2.99 kg/m 2 for controls, P = 0.028). In females, the mean BMI of patients with gastric dysplasia was significantly higher than that of controls (24.17 ± 3.47 kg/m 2 for gastric dysplasia patients vs 22.62 ± 3.14 kg/m 2 for controls, P \ 0.001). Relationship between obesity and the risk of gastric cancer and dysplasia Relationship between obesity and the risk of gastric cancer stratified by the gross classification, location, and histologic type of the tumor
The association between BMI and the risk of gastric cancer stratified by the gross tumor classification, location, and histologic type were examined in males (Table 5) and females ( In females, there were no statistically significant associations between BMI and any subgroup of gastric cancer (Table 6 )
Discussion
In this case-control study, the relationships between BMI and the risk of gastric cancer and dysplasia were investigated by considering the H. pylori infection status and other confounding factors in males and females. We observed that there were no significant relationships between obesity and the risk of gastric cancer or dysplasia in males. However, we found that obesity was related to an increased risk of EGC and well or moderately differentiated adenocarcinoma regardless of H. pylori infection in males, with the exception in males with BMI C 30 kg/m 2 . Although obesity was not related to an increased risk of gastric cancer or any subgroup of gastric cancer, a positive association between obesity and the risk of gastric dysplasia was seen in females, with the exception of females with BMI C 30 kg/m 2 . Previous case-control and cohort studies have shown the tendency of higher BMIs in patients with gastric cardia cancer. Several potential mechanisms have been proposed as underlying the relationship between an increased BMI and the risk of gastric cardia cancer. Obesity promotes gastroesophageal reflux by increasing intra-abdominal pressure [23] , which predisposes to Barrett's esophagus and thus to adenocarcinoma of the gastroesophageal junction [24] . Other mechanisms may also be involved, given that some studies have demonstrated a relationship between obesity and gastric cardia cancer regardless of gastroesophageal reflux [25] . The accumulation of adipose tissue induces multiple molecular changes such as hyperinsulinemia, elevated levels of insulin-like growth factors, adipokine imbalance, and increased estrogen levels, which can increase cell proliferation and impair apoptosis and consequently preneoplastic and neoplastic cell growth [26] . In addition, obesity has been recognized as a proinflammatory state leading to elevated levels of proinflammatory cytokines such as tumor necrosis factors and interleukin-6 [27] . By contrast, most previous studies have shown no relationship between obesity and gastric noncardia cancer. People at higher risk of gastric noncardia cancer are often heavy smokers and heavy drinkers, and thus are often malnourished. Further, a negative relationship between BMI and H. pylori infection is likely to be from another mechanism. H. pylori is suspected to be a cause of growth retardation during childhood [28] . H. pylori-related gastritis may have a direct effect on the reduction of food intake and impaired nutrient absorption. Moreover, achlorhydria after atrophic gastritis may increase the frequency of gastroenteritis, which may be associated with a lower BMI [29] . H. pylori infection is a well-established risk factor for gastric cancer, and H. pylori is classified as a type I carcinogen in humans [30] . H. pylori infection is known to increase the risk of gastric noncardia cancer, although no positive relationship between this infection and gastric cardia cancer has been found [31] . It is noteworthy that, according to a recent meta-analysis, H. pylori infection may be associated with an increased risk of gastric carida cancer in high-risk settings such as China, Japan, and Korea, but not in low-risk settings such as Western countries [12] . In addition, two distinct subtypes of cardia cancer have been suggested: reflux-related and H. pylorirelated [32] . Atrophic gastritis and intestinal metaplasia are known as factors that increase the risk of gastric cancer [33] , and many studies have shown that serum pepsinogen I levels and serum pepsinogen I/pepsinogen II ratios are related to gastric atrophy and putatively gastric cancer in clinical settings [20, 34] . A few studies have investigated the relationships between obesity and H. pylori infection [35] , gastric atrophy [36] , and the serum pepsinogen I/ pepsinogen II ratio [37] but produced mixed results. That is, each of these factors has been found to be less or similarly prevalent in obese individuals in comparison with normal ones. To the authors' knowledge, the present study is the first to investigate the relationship between BMI and gastric cancer by adjusting for the H. pylori infection status, atrophic gastritis, intestinal metaplasia, and the serum pepsinogen I/pepsinogen II ratio with almost complete coverage of other exposure factors based on a large cohort. A lack of studies considering the H. pylori infection status has been one of the major weaknesses in the literature on obesity and gastric cancer. In this study, the status of H. pylori infection in all subjects was evaluated by one of four methods, including histologic evaluation, the rapid urease test test, H. pyloric culture, and anti-H. pylori immunoglobulin G. The eradication history of H. pylori was also Table 5 The relationship between body mass index (BMI) and the risk of gastric cancer stratified by the gross classification, location, and histologic type of the tumor in males Table 6 The relationship between body mass index (BMI) and the risk of gastric cancer stratified by the gross classification, location, and histologic type of the tumor in females [38] . Through a combination of these comprehensive methods, past as well as current infection was investigated. Therefore, the consideration of data on the H. pylori infection status represents an important contribution of this study. Previous studies of the relationship between obesity and gastric cancer have generally been conducted in Western areas, in which the incidence of gastric cancer is lower and that of gastric cardia cancer is higher than that in Asian countries such as China, Japan, and Korea. Few studies have used Asian data, producing mixed results for the relationship between obesity and gastric cancer, particularly gastric cardia cancer [39] [40] [41] [42] [43] . Such mixed results may be explained as follows. First, the incidence of gastric cancer [44] and the prevalence of H. pylori infection [45] are higher in Asian countries than in Western ones, whereas the incidence of gastroesophageal reflux disease, Barrett's esophagus [46] , or morbid obesity [47] is lower in Asian countries. Second, the incidence of gastric cardia cancer is relatively low in Asia [31] . Third, the rate of overweight or obese patients remains relatively low, and obesity is less severe in Asian countries than in Western ones [47] . These epidemiologic differences between Asian and Western countries may be associated with the development of gastric cancer and may explain the lack of any relationship between obesity and gastric cardia cancer in Asia.
Staging differences related to BMI may be another potential confounding factor explaining the mixed findings of previous studies. In general, patients with gastric cancer tend to be cachexic with low BMIs as gastric cancer progresses to more advanced stages because such patients tend to have gastrointestinal symptoms such as epigastric pain, nausea, and anorexia, particularly in gastric outlet obstruction. Previous studies have shown significant decreased prevalence of T3-4 or N2-3 category cancer in patients with BMI C 25 kg/m 2 , although some studies have provided no relationship between BMI and the stage of gastric cancers [48, 49] . Previous studies suggesting a relationship between obesity and gastric cancers have generally ignored weight change from tumor progression and enrolled patients without considering the stage of their tumor. In the present study, obesity was related to EGC but not to AGC in males.
Previous [51] . In the present study, BMI C 25 kg/m 2 , which has been considered an accurate Asian standard, was used as a cutoff point for obesity, and this represents an important contribution of this study.
Only a few studies have addressed the relationship between obesity and gastric dysplasia. A Korean study [52] demonstrated that hyperglycemia and hypercholesterolemia are risk factors in gastric dysplasia, but that BMI is not positively related to gastric dysplasia (P trend = 0.845). Another study suggested a relationship between metabolic syndrome and gastric dysplasia in the general Korean population, but found no significant difference in the mean BMI between gastric dysplasia patients and controls (P = 0.05) [17] . However, these studies used fewer enrolled patients with gastric dysplasia than the present study (nearly three times as many cases). In addition, there was a significant relationship between obesity and gastric dysplasia in females even after other risk factors such as the H. pylori infection status had been controlled for in the present study.
In most regions, males have a higher age-specific incidence than do females [1] . This difference has been explained by a variation in environmental factors, including H. pylori infection, smoking, and different dietary patterns, as well as hormones such as estrogen [25, [53] [54] [55] . The finding that there is a significant association between obesity and the risk of EGC and differentiated-type gastric cancer in males but no association in females is intriguing and seems to support a modulatory effect by female sex hormones, although there is no clear evidence for such an effect from experimental studies. Further studies are needed to address this discrepancy in gender.
Our results showed that severe obesity (BMI C 30 kg/ m 2 ) was not significantly associated with the risk of gastric cancer, any subgroup of gastric cancer, and gastric dysplasia. The number of patients with severe obesity might be too small to show the association in the current study.
However, this study has a limitation in that abdominal obesity (waist circumference and the waist-to-hip ratio) and other risk factors in gastric cancer such as physical activity and socioeconomic status were not measured.
In sum, obesity, as measured by the BMI, was related to gastric cancer in the EGC and differentiated-type gastric cancer free from the influence of the H. pylori infection status in males. In addition, obesity was related to an increased risk of gastric dysplasia regardless of the H. pylori infection status in females. These results suggest that obesity treatment may help prevent gastric dysplasia and early gastric cancer.
